Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Targeting specific T cells may help treat alopecia areata.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Plant compounds may boost antiviral treatments.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.